
Leading UK oncologists have written an article in the May issue of The Lancet, strongly urging Britain to remain in …

Sarepta Therapeutics (NASDAQ: SPRT) is counting the cost as shares plunge following a negative review given by staff at the …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

